Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Kyntra Bio Inc (KYNB)

30 + Investors. Track Smart Money conviction in KYNB. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
47%

Smart Money Signals — KYNB

Based on 31 hedge funds · latest filing: 2026 Q1 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
31 hedge funds hold KYNB right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +3000% more funds vs a year ago

fund count last 6Q
+30 new funds entered over the past year (+3000% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 47% buying

16 buying18 selling
Last quarter: 18 funds reduced or exited vs 16 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~10 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 27 → 4 → 5 → 10. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 42% entered in last year

■ 10% conviction (2yr+) ■ 48% medium ■ 42% new
Only 3 funds (10%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares -20%, value -44%

Value
-43%
Shares
-20%
Last quarter: funds added -20% more shares while total portfolio value only changed -44%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
⚠️

Saturation — most institutions already know this story

0 → 27 → 4 → 5 → 10 new funds/Q
New funds entering each quarter: 27 → 4 → 5 → 10. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🌱

Early stage — 90% of holders entered in last year

■ 10% veterans ■ 0% 1-2yr ■ 90% new
Of 31 current holders: 28 (90%) entered in the past year, only 3 (10%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 11% AUM from top-100

11% from top-100 AUM funds
8 of 30 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.3
out of 10
Moderate Exit Risk
Exit risk score 5.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — KYNB

In 2026 Q1, 16 hedge funds were net buyers of KYNB (10 opened a new position, 6 added to an existing one), while 18 reduced or exited (8 trimmed, 10 sold completely) — a 47% buyer ratio, indicating roughly balanced activity. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 31.

Hedge Fund Ownership: KYNB

How many hedge funds hold KYNB — quarterly history vs. share price
Quarterly hedge fund ownership of KYNB vs. share price

Market Analysis: KYNB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: KYNB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Kyntra Bio Inc (KYNB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much KYNB has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 83d ago
KYNB
-1.2%
XLV
+705.0%

KYNB outperformed XLV by -706.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 38d ago
KYNB
-1.8%
XLV
+691.9%

Since the filing became public, KYNB outperformed XLV by -693.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: KYNB
30 + Investors

Track Smart Money conviction in KYNB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 30 31 -3.23%
13F Shares 1M 1M -20.13%
Total Value $7M $13M -43.63%
New Positions 9 5 +4
Increased Positions 5 7 -2
Closed Positions 10 5 +5
Reduced Positions 8 9 -1
Total Calls 1 1 -
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 1.0 Bullish

Statistics: KYNB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

30 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KYNB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 KYNB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Birchview Capital, LP 0.09% 22,566 $153K
2 Armistice Capital, LLC 0.05% 400,000 $2.7M
3 ADAR1 Capital Management, LLC 0.00% 10,469 $71K
4 Axiom Investment Management LLC 0.00% 704 $5K
5 Two Sigma Advisers, LP 0.00% 22,809 $200K
6 Renaissance Technologies LLC 0.00% 27,481 $186K
7 HighTower Advisors, LLC 0.00% 39,744 $269K
8 Two Sigma Investments, LP 0.00% 49,511 $336K
9 Susquehanna International Group, LLP 0.00% 89,400 $606K
10 Tower Research Capital LLC (TRC) 0.00% 332 $2K
11 Group One Trading LLC 0.00% 4,492 $30K
12 Vanguard Fiduciary Trust Co 0.00% 23,942 $162K
13 SBI Securities Co., Ltd. 0.00% 152 $1K
14 UBS Group AG 0.00% 27,591 $187K
15 Vanguard Capital Management LLC 0.00% 156,607 $1.1M
16 CFG Wealth Management Services, Inc. 0.00% 3 —
17 Harbour Investments, INC. 0.00% 200 $1K
18 Jane Street Group, LLC 0.00% 12,228 $83K
19 BlackRock, Inc. 0.00% 84,331 $572K
20 Osaic Holdings, INC. 0.00% 180 $1K
21 National Bank of Canada /Fi/ 0.00% 193 $1K
22 Cwm, LLC 0.00% 26 —
23 Morgan Stanley 0.00% 488 $3K
24 Royal Bank of Canada 0.00% 132 $1K
25 BNP Paribas Financial Markets 0.00% 50 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Kyntra Bio Inc (KYNB)

What does the Smart Money Trend signal show for KYNB?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for KYNB?

More sellers than buyers — 47% buying: Last quarter: 18 funds reduced or exited vs 16 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for KYNB holders?

Smaller funds dominant — 11% AUM from top-100: 8 of 30 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held KYNB?

Mostly new holders — 42% entered in last year: Only 3 funds (10%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Kyntra Bio Inc (KYNB) following the 2026 Q1 hedge fund 13F filings?

As of today, KYNB has moved -1.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +691.9% for the XLV sector ETF — an outperformance of -693.7%. Since the quarter end (March 31, 2026), KYNB has gained -1.2% vs +705.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →